Finance

Beta
Lists
1VT:FRA
Viking Therapeutics Inc
€25.60
+2.81%
(+0.70) 1D
Jun 5, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 1VT...
Open
€25.60
High
€25.60
Low
€25.60
Mkt. cap
3.30B
Avg. vol.
260.00
Volume
25.00
52-wk high
€39.10
52-wk low
€19.28
No. of employees
59
Open
€25.60
High
€25.60
Low
€25.60
Mkt. cap
3.30B
Avg. vol.
260.00
Volume
25.00
52-wk high
€39.10
52-wk low
€19.28
No. of employees
59
News stories
From sources across the web
About Viking Therapeutics Inc
CEOBrian Lian
Employees59
Founded2012
Headquarters-
SectorBiotechnology
Websitevikingtherapeutics.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
60.15M
89.95M
153.46M
150.15M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
14.42M
8.61M
11.28M
13.98M
Operating expense
74.57M
98.56M
164.74M
164.12M
Total operating expenses
74.57M
98.56M
164.74M
164.12M
Operating income
-74.57M
-98.56M
-164.74M
-164.12M
Other non operating income
-
-
-
-
EBT including unusual items
-65.56M
-90.79M
-157.66M
-158.32M
EBT excluding unusual items
-65.56M
-90.80M
-157.70M
-158.32M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-65.56M
-90.79M
-157.66M
-158.32M
Net profit margin
-
-
-
-
Earnings per share
-0.58
-0.81
-1.38
-1.37
Interest and investment income
9.03M
7.77M
7.04M
5.80M
Interest expense
-24.00K
-8.00K
-
-
Net interest expenses
9.01M
7.76M
7.04M
5.80M
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer